Therapeutic vaccines function by triggering a body immune response against a disease. The global therapeutic vaccines market was valued at USD 292 million in 2011. The introduction of therapeutic vaccines has opened up new avenues in the field of chronic disease treatment and prophylactic immunization. Provenge was the first U.S. FDA approved immunotherapy drug to treat prostate cancer in men in 2010, which has encouraged rigorous research and development initiatives by pharmaceutical companies to develop novel vaccines for untapped disease segments....
Wednesday, 31 July 2013
02:12
No comments
Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E. The most observed types of this disease are hepatitis A, hepatitis B and hepatitis C. Globally, 350 million people are chronically infected...
Tuesday, 30 July 2013
22:36
No comments
Lymphoma is a kind of blood cancer which occurs when B or T lymphocytes and leukocytes grow abnormally. In addition, it also occurs if these cells survive longer than their normal life cycle. Lymphoma generally occurs in lymph nodes, bone marrow, spleen, blood and other organs which form a part of the lymphatic system. The common symptoms of lymphoma are swelling of lymph nodes, fever, weight loss, night sweets, anorexia, itching, dyspnoea and fatigue. The common tests applied for the diagnosis of lymphoma are immunophenotyping, FISH (Fluorescence...
01:47
No comments
Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host organism by means of its replication or releasing variety of toxins in the host. Such infection causing micro-organisms include viruses, bacteria, fungi, viroids and macro parasites. Infections thus caused can be classified depending on the type of organism causing infection and the symptoms and medical signs shown by host.
Browse full report at: Anti-Infectives Market
The global market for...
Monday, 29 July 2013
01:32
No comments
Aptamers refer to short strands of nucleic acids or peptide molecules capable of forming secondary and tertiary structures. These molecules bind specifically to the cellular targets and are created by selecting randomly from the complex libraries of synthetic nucleic acids. These receptor molecules can be modified in order to enhance the stability and availability in biological environments. Aptamers possess potential applications in research, clinical, industrial and medical areas. Since the 1990s, aptamers have been tested for their clinical...
Thursday, 25 July 2013
03:58
No comments
Autacoids are certain biological factors that act like hormones and help in treating local injuries and other ailments. Autacoids are temporarily formed in the body and act locally. They have many different actions such as modulation of action of glands, smooth muscles, platelets, nerves, and other tissues. They are released by stimuli and when they are released into the body, they can bring certain changes such as itching, skin reddening, and bronchospasms. Some of these changes are undesirable and for the prevention of such symptoms, autacoids...
Wednesday, 24 July 2013
07:00
No comments
Market Research Reports : Transparency
Market Research published new market report "Pain Management Devices Market (Electrical Stimulators,
Radiofrequency Ablation, Analgesic Pumps, Neurostimulation Devices) -
Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012
- 2018", in 2011, the global pain management devices market
was valued at USD 2.0 billion and is expected to grow at a CAGR of 13.1% from 2012
to 2018 to reach a market of USD 5.0 billion by 2018.
Browse the full report at http://www.transparencymarketresearch.com/pain-management-drugs-devices.html
Increased
sophistication...
05:52
No comments
Market Research Reports : Transparency
Market Research published new market report "Aerospace Plastics Market for Fuselage,
Wings and Empennage Applications in Commercial Aircrafts,
Military Aircrafts, Rotary Aircrafts and General Aviation
- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 -
2018", the global aerospace plastics market was worth USD 6.2 billion
in 2011 and is expected to reach USD 10.5 billion in 2018, growing at a CAGR of
7.9% from 2012 to 2018. In terms of volume, the aerospace plastic consumption
was...
03:16
No comments
Market Research Reports : Transparency Market Research published new market report “Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market for Polymers (MCC, HPMC, CMC, Ethyl Cellulose, Povidone and Others), Alcohols (Glycerin, Sorbitol, Mannitol, Propylene Glycol), Minerals (Clay, Silicon Dioxide, Titanium Dioxide) and Sugars (Lactose, Sucrose) – Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018,” the global OSDF excipients demand was 93.8 kilo tons in 2011 and is expected to reach...
01:53
No comments
The generic drugs industry comprises of the manufacture and marketing of certain drugs which have the same active ingredients as the brand-name drugs manufactured by any pharmaceutical company. The major benefit of generic drugs is that the cost of such drugs is much less than that of branded drugs. Generic drugs come under the same governing framework as that of the brand-name drugs. The rationale behind generic drugs is that the patented drugs generally have a patent life of 20 years. However, the patent life of such drugs begins from the clinical...
Subscribe to:
Posts (Atom)
